Jim A. Julian

20.7k total citations · 5 hit papers
132 papers, 12.3k citations indexed

About

Jim A. Julian is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Jim A. Julian has authored 132 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Internal Medicine, 29 papers in Cardiology and Cardiovascular Medicine and 26 papers in Oncology. Recurrent topics in Jim A. Julian's work include Venous Thromboembolism Diagnosis and Management (49 papers), Atrial Fibrillation Management and Outcomes (22 papers) and Central Venous Catheters and Hemodialysis (19 papers). Jim A. Julian is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (49 papers), Atrial Fibrillation Management and Outcomes (22 papers) and Central Venous Catheters and Hemodialysis (19 papers). Jim A. Julian collaborates with scholars based in Canada, United States and France. Jim A. Julian's co-authors include Mark N. Levine, Michael Gent, Timothy J. Whelan, Agnes Lee, Michael J. Kovacs, Clive Kearon, Martin H. Prins, Ross Baker, Ajay K. Kakkar and Chris Bowden and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Jim A. Julian

131 papers receiving 11.8k citations

Hit Papers

Low-Molecular-Weight Heparin versus a Coumarin for the Pr... 2003 2026 2010 2018 2003 2010 2003 2003 2019 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
    2003 1.8k citations Agnes Lee, Mark N. Levine et al. New England Journal of Medicine profile →
  2. Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
    2010 1.3k citations Timothy J. Whelan, Jean‐Philippe Pignol et al. New England Journal of Medicine profile →
  3. A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome
    2003 591 citations Mark Crowther, Jim A. Julian et al. New England Journal of Medicine profile →
  4. Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
    2003 544 citations Clive Kearon, Jeffrey S. Ginsberg et al. New England Journal of Medicine profile →
  5. Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis
    2019 170 citations Anthony J. Comerota, Clive Kearon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jim A. Julian Canada 49 5.3k 3.5k 2.7k 2.4k 2.3k 132 12.3k
Alok A. Khorana United States 69 13.2k 2.5× 8.1k 2.3× 3.7k 1.4× 5.8k 2.4× 2.6k 1.1× 360 20.8k
Janet Dunn United Kingdom 46 930 0.2× 871 0.3× 3.1k 1.1× 6.5k 2.7× 3.0k 1.3× 253 11.2k
Anthony Maraveyas United Kingdom 31 1.9k 0.4× 1.3k 0.4× 4.2k 1.6× 3.9k 1.6× 2.5k 1.1× 165 8.4k
Eva Culakova United States 38 3.0k 0.6× 1.7k 0.5× 755 0.3× 2.8k 1.1× 860 0.4× 180 7.0k
Nicole M. Kuderer United States 42 6.1k 1.1× 3.7k 1.1× 1.7k 0.6× 4.6k 1.9× 1.3k 0.6× 133 12.4k
Sameer Parpia Canada 26 780 0.1× 592 0.2× 778 0.3× 978 0.4× 528 0.2× 127 3.6k
Alex Balekian United States 10 1.8k 0.3× 1.2k 0.3× 978 0.4× 526 0.2× 1.8k 0.8× 15 3.9k
Anna Falanga Italy 65 9.2k 1.7× 5.3k 1.5× 2.3k 0.9× 2.5k 1.0× 1.5k 0.7× 299 16.8k
Sylvie Chabaud France 35 330 0.1× 790 0.2× 1.1k 0.4× 1.6k 0.7× 2.3k 1.0× 191 5.6k
Adam Torbicki Poland 50 3.0k 0.6× 10.6k 3.0× 1.7k 0.6× 983 0.4× 9.7k 4.2× 263 15.3k

Countries citing papers authored by Jim A. Julian

Since Specialization
Citations

This map shows the geographic impact of Jim A. Julian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim A. Julian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim A. Julian more than expected).

Fields of papers citing papers by Jim A. Julian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim A. Julian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim A. Julian. The network helps show where Jim A. Julian may publish in the future.

Co-authorship network of co-authors of Jim A. Julian

This figure shows the co-authorship network connecting the top 25 collaborators of Jim A. Julian. A scholar is included among the top collaborators of Jim A. Julian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim A. Julian. Jim A. Julian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Julian, Jim A., Clare Liddy, Amir Afkham, et al.. (2023). Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial. Journal of Medical Internet Research. 25. e40725–e40725. 4 indexed citations
2.
Arsenault, Julie, Sameer Parpia, Eileen Rakovitch, et al.. (2020). Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 107(5). 943–948. 46 indexed citations
3.
Wit, Kerstin de, Sam Schulman, Fred Spencer, et al.. (2020). Deep Vein Thrombosis Diagnosis with D-Dimer Adjusted to Clinical Probability. Blood. 136(Supplement 1). 20–20. 1 indexed citations
4.
Kearon, Clive, Kerstin de Wit, Sameer Parpia, et al.. (2019). Diagnosis of Pulmonary Embolism with d -Dimer Adjusted to Clinical Probability. New England Journal of Medicine. 381(22). 2125–2134. 188 indexed citations
5.
6.
Levine, Mark N., Jim A. Julian, Philippe L. Bédard, et al.. (2015). Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario. Journal of Clinical Oncology. 34(10). 1065–1071. 60 indexed citations
7.
Parpia, Sameer, Jim A. Julian, Lehana Thabane, et al.. (2014). Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer. BMJ Open. 4(10). e006531–e006531. 2 indexed citations
8.
Olivotto, Ivo A., Timothy J. Whelan, Sameer Parpia, et al.. (2013). Interim Cosmetic and Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation Using Three-Dimensional Conformal External Beam Radiation Therapy. Journal of Clinical Oncology. 31(32). 4038–4045. 266 indexed citations
9.
Linkins, Lori‐Ann, Shannon M. Bates, Eddy Lang, et al.. (2013). Selective D-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis. Annals of Internal Medicine. 3 indexed citations
10.
Darling, Gail, Donna E. Maziak, Richard Inculet, et al.. (2011). Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography Trial. Journal of Thoracic Oncology. 6(8). 1367–1372. 113 indexed citations
11.
12.
Whelan, Timothy J., Jean‐Philippe Pignol, Mark N. Levine, et al.. (2010). Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer. New England Journal of Medicine. 362(6). 513–520. 1260 indexed citations breakdown →
13.
O’Malley, Frances P., Tom Thomson, Jim A. Julian, et al.. (2008). HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab.. Archives of Pathology & Laboratory Medicine. 132(1). 61–5. 23 indexed citations
14.
McRae, Simon, Susan R. Kahn, Jim A. Julian, et al.. (2008). Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS). Thrombosis and Haemostasis. 99(3). 623–629. 62 indexed citations
15.
Kearon, Clive, Jim A. Julian, Michael J. Kovacs, et al.. (2008). Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood. 112(12). 4432–4436. 81 indexed citations
16.
Kearon, Clive, Jeffrey S. Ginsberg, James D. Douketis, et al.. (2006). An Evaluation of D-Dimer in the Diagnosis of Pulmonary Embolism. Annals of Internal Medicine. 7 indexed citations
17.
Male, Christoph, et al.. (2005). Significant association with location of central venous line placement and risk of venous thrombosis in children. Thrombosis and Haemostasis. 94(9). 516–521. 81 indexed citations
18.
Crowther, Mark, Catherine M. Clase, Peter J. Margetts, et al.. (2002). Low-Intensity Warfarin Is Ineffective for the Prevention of PTFE Graft Failure in Patients on Hemodialysis. Journal of the American Society of Nephrology. 13(9). 2331–2337. 130 indexed citations
19.
Whelan, Timothy J., Mark N. Levine, Jim A. Julian, Peter Kirkbride, & Peter Skingley. (2000). The effects of radiation therapy on quality of life of women with breast carcinoma. Cancer. 88(10). 2260–2266. 8 indexed citations
20.
Lee, Agnes, Jim A. Julian, Mark N. Levine, et al.. (1999). Clinical Utility of a Rapid Whole-Blood d-Dimer Assay in Patients with Cancer Who Present with Suspected Acute Deep Venous Thrombosis. Annals of Internal Medicine. 131(6). 417–423. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alok A. Khorana Breakdown of academic impact, for papers by Janet Dunn Breakdown of academic impact, for papers by Anthony Maraveyas Breakdown of academic impact, for papers by Eva Culakova Breakdown of academic impact, for papers by Nicole M. Kuderer Breakdown of academic impact, for papers by Sameer Parpia Breakdown of academic impact, for papers by Alex Balekian Breakdown of academic impact, for papers by Anna Falanga Breakdown of academic impact, for papers by Sylvie Chabaud Breakdown of academic impact, for papers by Adam Torbicki
Rankless by CCL
2026